[Federal Register Volume 70, Number 228 (Tuesday, November 29, 2005)]
[Notices]
[Pages 71560-71561]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-6592]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 2, 2005, and published in the Federal Register 
on June 10, 2005, (70 FR 33923), Research Triangle Institute, Kenneth 
H. Davis Jr., Herman Building, P.O. Box 12194, East Institute Drive, 
Research Triangle Park, North Carolina 27709, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed in Schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Cocaine (9041).............................  II
------------------------------------------------------------------------

    The Institute will manufacture small quantities of cocaine and 
marihuana derivatives for use by their customers primarily in 
analytical kits, reagents and reference standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Research Triangle Institute to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Research Triangle Institute to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included

[[Page 71561]]

inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: November 21, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. E5-6592 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P